Letter: cohort study examining the association between proton pump inhibitors therapy and risk of hepatocellular carcinoma in Taiwan-authors' reply

Aliment Pharmacol Ther. 2018 Sep;48(6):690-691. doi: 10.1111/apt.14935.
No abstract available

Publication types

  • Letter
  • Comment

MeSH terms

  • Carcinoma, Hepatocellular*
  • Cohort Studies
  • Humans
  • Liver Neoplasms*
  • Proton Pump Inhibitors
  • Taiwan

Substances

  • Proton Pump Inhibitors